Analyst Ratings for Harris Corp. (HRS)
HRS Rating Summary
HRS Price Target Summary
- Highest: $44.00 (Barclays)
- Lowest: $38.00 (Benchmark)
- Average: $40.67
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$40.67 (-19.3%)
Avg. $ Target:
$40.67 (-19.3%)
| Date | Firm | Type | Rating (Past) |
PT (Past) |
Start $ | End $ | % Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/21/2013 | Stifel Nicolaus | New Coverage | Hold (N/A) |
N/A (N/A) |
50.36 | 50.37 | 0.02% | Details |
| 3/6/2013 | Oppenheimer | Downgrade | Underperform (Perform) |
N/A (N/A) |
47.23 | 50.37 | 6.65% | Details |
| 1/8/2013 | JPMorgan | Downgrade | Underweight (Neutral) |
N/A (N/A) |
50.07 | 50.37 | 0.6% | Details |
| 10/15/2012 | Lazard Capital | Downgrade | Sell (Neutral) |
N/A (N/A) |
48.84 | 50.37 | 3.13% | Details |
| 5/2/2012 | Standpoint Research | Downgrade | Hold (N/A) |
N/A (N/A) |
42.97 | 50.37 | 17.22% | Details |
| 5/1/2012 | Raymond James | Downgrade | Market Perform (N/A) |
N/A (N/A) |
45.54 | 50.37 | 10.61% | Details |
| 4/25/2012 | Drexel Hamilton | New Coverage | Hold (N/A) |
N/A (N/A) |
43.83 | 50.37 | 14.92% | Details |
| 1/23/2012 | Barclays | Downgrade | Equalweight (N/A) |
44.00 (N/A) |
39.40 | 50.37 | 27.84% | Details |
| 1/6/2012 | Sterne Agee | New Coverage | Neutral (N/A) |
N/A (N/A) |
36.68 | 50.37 | 37.32% | Details |
| 10/7/2011 | Benchmark | Downgrade | Hold (N/A) |
38.00 (N/A) |
35.99 | 50.37 | 39.96% | Details |
| 8/15/2011 | Merriman Capital | Downgrade | Neutral (N/A) |
N/A (N/A) |
36.70 | 50.37 | 37.25% | Details |
| 6/17/2011 | Goldman Sachs » Updated 10/28/2011 |
New Coverage | Neutral (N/A) |
40.00 (N/A) |
44.15 | 50.37 | 14.09% | Details |
| 4/18/2011 | Gleacher & Co. | New Coverage | Buy (N/A) |
N/A (N/A) |
50.05 | 50.37 | 0.64% | Details |
| 4/4/2011 | SunTrust Robinson Humphrey | Upgrade | Buy (N/A) |
N/A (N/A) |
50.05 | 50.37 | 0.64% | Details |
| 3/21/2011 | Buckingham Research | Upgrade | Buy (N/A) |
N/A (N/A) |
46.52 | 50.37 | 8.28% | Details |
